Nextcure, Inc. · NASDAQ:NXTC
Simcere Zaiming, Inc. reported a 12.70% stake in Nextcure, Inc. (Schedule 13G)
Event Jun 20, 2025 · Filed Aug 19, 2025
Simcere Zaiming, Inc. reported a 12.70% stake in Nextcure, Inc., 338,636 shares, as a passive investor on Jun 20, 2025. Filed Aug 19, 2025 (Schedule 13G).
- Stake
- 12.70%
- Shares
- 338,636
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Simcere Zaiming, Inc. | 12.70% | 338,636 |
| Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. | 12.70% | 338,636 |
| Hainan Simcere Zaiming Pharmaceutical Co., Ltd. | 12.70% | 338,636 |
| Simcere Pharmaceutical Group Limited | 12.70% | 338,636 |
| Ren Jinsheng | 12.70% | 338,636 |
| Tang Renhong | 12.70% | 338,636 |
Source
Related
- Nextcure, Inc.
- Simcere Zaiming, Inc.
- Nextcure, Inc. shareholders
- Schedule 13G/A · Simcere Zaiming, Inc. · May 6, 2026
- Schedule 13G · JP Sailing Capital Ltd · Oct 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026